Logo for aTyr Pharma Inc

aTyr Pharma Investor Relations Material

Latest events

Logo for aTyr Pharma Inc

Q4 2024

aTyr Pharma
Logo for aTyr Pharma

Q1 2025

30 May, 2025
Logo for aTyr Pharma

Q4 2024

13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from aTyr Pharma Inc

Access all reports
aTyr Pharma Inc. is a biotherapeutics company focused on the discovery and development of innovative medicines based on extracellular proteins to treat rare immune, inflammatory, and fibrotic diseases. The company's research is centered around the therapeutic potential of tRNA synthetase biology. aTyr's lead clinical program targets lung diseases with unmet medical needs, particularly those related to inflammation and fibrosis. The company aims to advance novel treatments that address the underlying causes of these conditions. The company is headquartered in San Diego, California, USA, and its shares are listed on the NASDAQ.